2022
Association of Prepregnancy Substance Use and Substance Use Disorders with Pregnancy Timing and Intention
Coy KC, Ko JY, Ondersma SJ, Gilstad-Hayden K, Zapata LB, Chang G, Yonkers K. Association of Prepregnancy Substance Use and Substance Use Disorders with Pregnancy Timing and Intention. Journal Of Women's Health 2022, 31: 1630-1638. PMID: 35352988, PMCID: PMC10970710, DOI: 10.1089/jwh.2021.0483.Peer-Reviewed Original ResearchConceptsSubstance use disordersSubstance usePregnancy timingUse disordersRobust error varianceConfidence intervalsPrenatal care sitesPostpartum carePregnancy intentionPrevalence ratiosIntended pregnanciesCare sitesPoisson regressionSecondary analysisIndependent relationshipPregnancyRelevant covariatesTotal sample sizeFamily planningWomenAssociationDisordersSupport Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics
Forray A, Mele A, Byatt N, Tobon A, Gilstad-Hayden K, Hunkle K, Hong S, Lipkind H, Fiellin DA, Callaghan K, Yonkers KA. Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics. PLOS ONE 2022, 17: e0261751. PMID: 35025898, PMCID: PMC8758001, DOI: 10.1371/journal.pone.0261751.Peer-Reviewed Original ResearchConceptsOpioid use disorderPregnant womenUse disordersPrenatal clinicsClinical trialsReproductive health cliniciansCollaborative care approachTRIAL REGISTRATION NUMBERCommunity Healthcare OutcomesMatched-pair clusterPatient treatment engagementTreatment modelObstetric providersOUD treatmentPrimary outcomeObstetrical providersPostpartum womenHealth cliniciansCare approachRegistration numberTreatment engagementRelated treatmentsHealthcare outcomesTrialsWomen
2021
Progression of depression and anxiety symptoms in pregnancies conceived by assisted reproductive technology in the United States
Simoni MK, Gilstad-Hayden K, Naqvi SH, Pal L, Yonkers KA. Progression of depression and anxiety symptoms in pregnancies conceived by assisted reproductive technology in the United States. Journal Of Psychosomatic Obstetrics & Gynecology 2021, 43: 214-223. PMID: 34472405, PMCID: PMC10116357, DOI: 10.1080/0167482x.2021.1971193.Peer-Reviewed Original ResearchConceptsAssisted-reproductive technologyEdinburgh Postnatal Depression ScalePlanned pregnanciesPostnatal Depression ScaleGestational time periodsART pregnanciesProspective cohortPregnant womenWeeks postpartumGeneralized Estimating EquationsObstetrical practiceDepression ScaleDepressive symptomsPregnancyBlue studiesSecondary analysisConception groupMental healthAnxiety subscaleAnxiety symptomsWomenGroup changesSymptomsPrevalenceWeeks“A good mother”: Impact of motherhood identity on women's substance use and engagement in treatment across the lifespan
Adams ZM, Ginapp CM, Price CR, Qin Y, Madden LM, Yonkers K, Meyer JP. “A good mother”: Impact of motherhood identity on women's substance use and engagement in treatment across the lifespan. Journal Of Substance Use And Addiction Treatment 2021, 130: 108474. PMID: 34118710, PMCID: PMC8478714, DOI: 10.1016/j.jsat.2021.108474.Peer-Reviewed Original ResearchConceptsSUD treatmentSubstance useSubstance use disorder treatmentSUD treatment programsUse disorder treatmentWomen's substance usePostpartum periodMost womenStudy staffIndependent authorsTreatment engagementDisorder treatmentTreatment programWomenSUD recoveryTreatmentMothersSpecific barriersChildrenResidential programsMiddle adulthoodFocus groupsCaretakersQualitative interviewsPregnancy
2020
Abstinence outcomes among women in reproductive health centers administered clinician or electronic brief interventions
Yonkers KA, Dailey JI, Gilstad-Hayden K, Ondersma SJ, Forray A, Olmstead TA, Martino S. Abstinence outcomes among women in reproductive health centers administered clinician or electronic brief interventions. Journal Of Substance Use And Addiction Treatment 2020, 113: 107995. PMID: 32359666, PMCID: PMC8372233, DOI: 10.1016/j.jsat.2020.02.012.Peer-Reviewed Original ResearchConceptsElectronic brief interventionBrief interventionUsual careSubstance useAbstinence outcomesEnhanced usual care conditionEnhanced usual careUsual care conditionReproductive health centersRandomized clinical trialsReproductive healthcare servicesReproductive healthcare clinicsE-SBIRTAbstinence ratesPoint prevalenceClinical trialsHealth centersCare conditionsHealthcare clinicsSecondary analysisReproductive healthcareWomenAbstinenceInterventionHealthcare services
2019
Identification of substance use disorders among pregnant women: A comparison of screeners
Chang G, Ondersma SJ, Blake-Lamb T, Gilstad-Hayden K, Orav EJ, Yonkers KA. Identification of substance use disorders among pregnant women: A comparison of screeners. Drug And Alcohol Dependence 2019, 205: 107651. PMID: 31683243, DOI: 10.1016/j.drugalcdep.2019.107651.Peer-Reviewed Original ResearchConceptsSubstance use disordersPregnant womenUse disordersAlcohol use disorderDrug use questionnaireMINI diagnostic interviewRate of useMean ageDiagnostic criteriaQuick screenDiagnostic InterviewIdeal questionnaireCRAFFTDisordersWomenModest abilityReference standardUse QuestionnaireQuestionnaireScreener
2017
Postpartum Contraceptive use and Rapid Repeat Pregnancy Among Women who use Substances
Loree AM, Gariepy A, Ruger JP, Yonkers KA. Postpartum Contraceptive use and Rapid Repeat Pregnancy Among Women who use Substances. Substance Use & Misuse 2017, 53: 162-169. PMID: 28937912, PMCID: PMC6025459, DOI: 10.1080/10826084.2017.1327976.Peer-Reviewed Original ResearchConceptsRapid repeat pregnancyPostpartum contraceptive useRepeat pregnancyContraceptive usePostpartum womenRandomized clinical trialsOB/GYN clinicPrenatal substance exposureEffective contraceptive useIllicit drug useContraceptive initiationWeeks' gestationPregnant womenSubstance use historiesPostpartum contraceptionClinical trialsSubstance exposurePregnancyDrug useSecondary analysisIllicit substancesSubstance useWomenUse historyDepoProvera
2015
Perinatal substance use: A prospective evaluation of abstinence and relapse
Forray A, Merry B, Lin H, Ruger JP, Yonkers KA. Perinatal substance use: A prospective evaluation of abstinence and relapse. Drug And Alcohol Dependence 2015, 150: 147-155. PMID: 25772437, PMCID: PMC4387084, DOI: 10.1016/j.drugalcdep.2015.02.027.Peer-Reviewed Original ResearchConceptsRates of abstinenceMean daysSubstance useMultivariate Cox modelLittle prospective dataPostpartum relapseRelapse postpartumAbstinence ratesProspective evaluationNicotine cigarettesProspective dataCox modelPregnancyRelapseCigarettesAbstinenceToxicology testingCocaineWomenPsychological treatmentLast monthPostpartumMarijuanaSpecific substancesDays
2012
Premenstrual Dysphoric Disorder: Evidence for a New Category for DSM-5
Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, Yonkers KA. Premenstrual Dysphoric Disorder: Evidence for a New Category for DSM-5. American Journal Of Psychiatry 2012, 169: 465-475. PMID: 22764360, PMCID: PMC3462360, DOI: 10.1176/appi.ajp.2012.11081302.Peer-Reviewed Original Research
2008
Premenstrual syndrome
Yonkers KA, O'Brien P, Eriksson E. Premenstrual syndrome. The Lancet 2008, 371: 1200-1210. PMID: 18395582, PMCID: PMC3118460, DOI: 10.1016/s0140-6736(08)60527-9.Peer-Reviewed Original ResearchConceptsSevere premenstrual syndromePremenstrual dysphoric disorderPremenstrual syndromeSerotonin reuptake inhibitorsGonadal hormone levelsGonadotropin-releasing hormoneOral contraceptivesReuptake inhibitorsBreast tendernessSerotonergic synapsesReproductive ageHormone levelsDysphoric disorderLuteal phaseOvary axisMost womenOvarian cyclicityBehavioral symptomsDepressed moodSymptomsMood swingsSomatic complaintsPhysical discomfortWomenDaily activities
2005
Pretreatment pattern of symptom expression in premenstrual dysphoric disorder
Pearlstein T, Yonkers KA, Fayyad R, Gillespie JA. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. Journal Of Affective Disorders 2005, 85: 275-282. PMID: 15780697, DOI: 10.1016/j.jad.2004.10.004.Peer-Reviewed Original ResearchConceptsPremenstrual dysphoric disorderPMDD symptomsMenstrual cycleDysphoric disorderPatient variabilityIntermittent dosing strategyOnset of menstruationDSM-IV criteriaPatients' durationAnxiety/tensionSertraline treatmentDRSP scoresPatient daysDosing strategiesSevere symptomsDay 2SymptomsTreatment studiesPretreatment patternAnger/irritabilityMood swingsMore daysWomenSymptom expressionTreatment implications
2004
Management of Bipolar Disorder During Pregnancy and the Postpartum Period
Yonkers KA, Wisner KL, Stowe Z, Leibenluft E, Cohen L, Miller L, Manber R, Viguera A, Suppes T, Altshuler L. Management of Bipolar Disorder During Pregnancy and the Postpartum Period. American Journal Of Psychiatry 2004, 161: 608-620. PMID: 15056503, DOI: 10.1176/appi.ajp.161.4.608.Peer-Reviewed Original ResearchConceptsMood stabilizersBipolar disorderPostpartum periodFuture reproductive plansBipolar disorder patientsIssue of pregnancyPeripartum womenCohort studyPostpartum womenPregnant womenSodium valproateDisturbed sleepReproductive yearsHuman teratogenPsychotic componentsGeneral populationDisorder patientsPregnancyConsensus documentAmerican Psychiatric AssociationReproductive plansDisordersEarly adulthoodExpert panelWomen